BPG is committed to discovery and dissemination of knowledge
Randomized Controlled Trial
Copyright: ©Author(s) 2026.
World J Gastrointest Pharmacol Ther. Jun 5, 2026; 17(2): 118848
Published online Jun 5, 2026. doi: 10.4292/wjgpt.v17.i2.118848
Table 1 Demographic and clinical variables of 36 patients randomized into group 1 and group 2, n (%)
Variable
Group 1 (control or no traction; n = 18)
Group 2 (study group with dynamic traction on the laparostomy bag; n = 18)
P value
Mean age (years ± SD)43.78 ± 11.6641.61 ± 15.670.6410
Male:female ratio1:14:51.000
Primary laparostomy creation2 (11.11)5 (27.78)1.000
Needing re-application of laparostomy 3 (16.67)6 (33.33)1.000
Creation of stoma13 (72.2)10 (55.6)1.000
Comorbidity
Hypertension1 (5.56)1 (5.56)1.000
Diabetes mellitus7 (38.89)6 (33.33)
Chronic liver disease1 (5.56)0
Pulmonary disease1 (5.56)1 (5.56)
Etiology
Tuberculosis6 (33.33)6 (33.33)0.76
Enteric fever7 (38.89)5 (27.78)
Trauma1 (5.56)3 (16.67)
Ruptured liver abscess2 (11.11)3 (16.67)
Others2 (11.11)1 (5.56)
Investigations
Abnormal liver function tests 8 (44.4)10 (55.6)0.74
Mean INR1.65 ± 0.5681.66 ± 0.4860.915
Mean serum creatinine (mg/dL ± SD)1.61 ± 0.6241.61 ± 0.6241.00
Mean serum albumin (g/dL ± SD)2.80 ± 0.5702.76 ± 0.5340.829
Viral markers positive (HBsAg, HIV, HCV)2 (11.11)1 (5.56)1.00
Mean blood transfusion units per patient1.671.831.000
SOFA score > 9 at admission 4 (22.2)4 (22.2)1.000
Mean initial fascial gap (cm ± SD)14.2 ± 2.315.1 ± 2.11.000
Table 2 Outcome parameters in 36 patients randomized into group 1 group 2
Variable
Group 1 (control or no traction; n = 18)
Group 2 (study group with dynamic traction on the laparostomy bag; n = 18)
P value
Mean day of starting oral intake (± SD)2.83 ± 1.202.83 ± 0.830.115
Mean days of TPN (± SD)2.5 ± 1.892.89 ± 1.280.47
Mean days to achieve 5 cm skin-to-skin distance (± SD)13 ± 2.879.94 ± 1.880.0003a
Mean hospital stay (days ± SD)20.39 ± 3.1717.0 ± 1.850.0013a
Mortality (%)1 (5.56)1 (5.56)1.000
Follow-up rate at 6 weeks (%)100100-
Follow-up rate at 3 months (%)33391.000
Incisional hernia at last follow-up00-
Table 3 Innovative techniques for dynamic fascial traction for the open abdomen
Ref.
Study design and population
Technique
Key results
Remarks
Fung et al[6]Retrospective multicenter case series; 9 patients in critical care units (including sepsis and bowel ischemia); 12 received concomitant NPWT and 8 had Bogota bag coverageFasciotens™ device providing vertical sustained traction using a stand with suspended thread retainer; fascial sutures tightened using screw mechanismMean OA duration: 3 days; mean initial fascial gap: 15 cm with significant reduction to 10 cm (P = 0.0081); mean time to DFC: 7 days; comparable outcomes in septic and non-septic OA (7.5 days vs 7 days); two long-term incisional hernias; no procedure-related mortalityHigh cost (approximately ₹3 Lakh per unit); heterogeneous etiologies; limited applicability due to simultaneous use of multiple techniques
Dohmen et al[18]Retrospective case series; 9 critically ill patients (including sepsis and bowel ischemia)Fasciotens™ device with vertical sustained tractionMortality: 3 patients; mean OA procedures: 3 ± 1; mean time to DFC: 9 ± 3 days; 76% reduction in fascia-to-fascia gap; intra-abdominal pressure reduced from 31 ± 8 mmHg to 8.5 ± 2 mmHg; skin irritation and blisters in 3 casesHigh cost (~₹3 Lakh per unit)
Mones et al[19]Retrospective case series; 9 patients (2 vascular, 7 abdominal surgery)Fasciotens™ device with vertical sustained tractionDFC achieved in 7 of 9 cases; mean OA duration: 9.6 ± 3.8 days; mean initial fascial gap: 14.2 ± 4.0 cm; mean time to DFC after VMMFT: 6.2 ± 3.5 days; no method-related complicationsHigh cost (~₹3 Lakh per unit); heterogeneous patient population
Pereira-Warr et al[20]Retrospective case series; 8 patients with sepsis, bowel ischemia, or bowel edemaViscera covered with perforated plastic sheet; suction drain tubing sutured longitudinally to fascia on both sides; additional drain passed circumferentially to provide gradual fascial tighteningMean OA procedures: 2.4; mean initial fascial gap: 16.8 cm; mean time to DFC: 9.1 days; mean ICU stay: 43.6 days; no 30-day mortality or major complicationsLow-cost, bedside, feasible technique; fenestrated drains obviate need for NPWT; DFC feasible when gap is 3-7 cm; stomas do not interfere with closure
Dennis et al[21]Retrospective case series; 32 patients (predominantly trauma follow-up cases)Modified Wittmann patch with indigenous transabdominal wall traction device anchored to lateral abdominal wall; medial traction achieved by tightening external bolsters; NPWT used concomitantlyMean initial fascial gap: 18.5 cm × 30.5 cm; mean OA procedures: 2.2; mean time to DFC: 18.2 days; mean reduction in wound size: 9.8 cm (51.4%); ECF in 4 cases; no incisional hernia or dehiscence; no procedure-related mortalityCost-effective and indigenous; requires repeated anesthesia and operating-room interventions; intensive training required; DFC endpoint of 2 cm used
Jo Svetanoff et al[22]Retrospective case series; 3 pediatric patientsBedside techniques including reinforced silastic silos sutured to fascia with thick polypropylene or polyethylene sutures; DFT achieved using 20-pound weights in two patients; botulinum toxin, horizontal mattress sutures, and NPWT used in one patientInitial fascial gap: 10-18 cm; OA procedures: 2-3; DFC achieved in 7-10 days in all casesBedside tightening feasible due to polyethylene (Ethibond™) sutures; pediatric patients require tailored approaches due to lower abdominal volume and frequent ACS


Write to the Help Desk